For 70 years we've waged war against harmful bacteria using antibiotics. But bacteria are fighting back and today more and more bacterial infections are becoming resistant to antibiotics. Drug-resistant superbugs are spreading; not just MRSA - also TB, pneumonia, e-coli. In Britain, hundreds are already dying of these infections - mainly the very young or the frail and elderly. But experts warn that unless we crack the problem, by 2050 we'll be facing a massive health crisis with over 10 million people dying of resistant bacterial infection worldwide every year.
Nearly one-third of adults engage in problem drinking at some point in their lives. Health professionals assess drinkers at risk on a spectrum ranging from low-risk to an alcohol use disorder that can range from mild to severe. Risky Drinking challenges viewers to recognize when their drinking may be putting them at risk and offers information that could help millions of people lead healthier lives. Through case studies and expert analysis, the film investigates the broad spectrum of risky drinking at different ages and stages in people’s lives,
2017 • Health
Michael Mosley investigates the dramatic rise in e-cigarettes. They're everywhere these days, but what does the latest scientific research on them reveal? Michael reveals what e-cigarettes are really doing to your health. Are they really better for you than cigarettes? What is actually in them? Is passive vapour harmful? And can they really stop you from smoking? Michael meets some of the scientists around the world studying them, asks a group of volunteers to try to give up smoking regular cigarettes using them, and even takes up 'vaping' himself, smoking an e-cigarette every day for a month to see the effects on his own health - no easy task for such a committed non-smoker.
We bring you a special episode, celebrating the award of this year's Nobel Prize in Physiology or Medicine to Tasuku Honjo, Distinguished Professor at Kyoto University. His basic research has led to the development and clinical applications of Opdivo, a groundbreaking new anti-cancer drug that works with immune cells. It has given hope to many cancer patients, and surprised clinical specialists. We'll explore what innovation Opdivo has brought to cancer treatment, and what challenges remain.
Diseases that were largely eradicated in the United States a generation ago—whooping cough, measles, mumps—are returning, in part because nervous parents are skipping their children’s shots. NOVA's "Vaccines—Calling the Shots" takes viewers around the world to track epidemics, explore the science behind vaccinations, hear from parents wrestling with vaccine-related questions, and shed light on the risks of opting out.
Michael Mosley puts himself through a battery of health tests available to people who feel perfectly well. From an expensive heart scan to a new national screening procedure to detect the earliest signs of bowel cancer, Mosley sets out to discover which if any of the tests are worth doing.
Is there any way to slow or even prevent the ravages of time? Veteran presenter Johnny Ball looks back over the 45 years that Horizon, and he, have been on air to find out what science has learned about how and why we grow old. Charting developments from macabre early claims of rejuvenation to the latest cutting-edge breakthroughs, Johnny discovers the sense of a personal mission that drives many scientists and asks whether we are really any closer to achieving the dream of immortality.